Skip to content

Released Aug 12, 2021, after the close

10-Q filed Aug 12, 2021, 43 days after period end · 0001789769-21-000052

Q2 2021 · 10-Q
Revenue$0.00−100.0% vs Q2 2020no prior Q1 2021 on file
Net Income-$35.31MN/M vs Q2 2020N/M vs Q1 2021
EPS Diluted-$0.27N/M vs Q2 2020N/M vs Q1 2021
Operating Income-$35,381,000N/M
Operating Cash Flowderived-$32,224,000N/M
Free Cash Flowderived-$40,717,000N/M

What the release said

The release

Same quarter

MetricQ2 2021Q2 2020
Revenue$0.00$42.00K
Net Income-$35.31M-$9.20M
EPS Diluted-$0.27-$0.55

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Instil Bio, Inc. · CIK 1789769 · Engraved from SEC EDGAR